Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic

J Am Acad Dermatol. 2009 Aug;61(2):271-5. doi: 10.1016/j.jaad.2009.03.033. Epub 2009 May 28.

Abstract

Background: Having either mycosis fungoides or B-cell lymphoma may predispose a patient to the other.

Objective: We sought to determine whether the contemporaneous occurrence of the two malignancies is greater than chance and to investigate possible risk factors for the second malignancy.

Methods: We retrospectively reviewed the records of patients with contemporaneous mycosis fungoides and B-cell lymphoma seen between 1990 and 2007 at Mayo Clinic, Rochester, MN, or at Mayo Clinic, Scottsdale, AZ.

Results: In all, 23 patients had contemporaneous mycosis fungoides and B-cell malignancy. The first diagnosis was mycosis fungoides in 10 patients and B-cell lymphoma in 7; in 6 patients, the diseases were diagnosed simultaneously. No therapeutic factors could account for a predisposition to a second malignancy.

Limitations: Retrospective design, referral center, and small sample size are limitations.

Conclusion: Mycosis fungoides and B-cell lymphoma are unlikely to occur contemporaneously by chance, but no factor obviously predisposes a patient with one malignancy to development of the second.

MeSH terms

  • Academic Medical Centers
  • Adult
  • Age Distribution
  • Age of Onset
  • Aged
  • Biopsy, Needle
  • Cohort Studies
  • Comorbidity
  • Female
  • Humans
  • Immunohistochemistry
  • Incidence
  • Lymphoma, B-Cell / epidemiology*
  • Lymphoma, B-Cell / pathology*
  • Lymphoma, B-Cell / therapy
  • Lymphoma, T-Cell, Cutaneous / epidemiology
  • Lymphoma, T-Cell, Cutaneous / pathology
  • Lymphoma, T-Cell, Cutaneous / therapy
  • Male
  • Middle Aged
  • Mycosis Fungoides / epidemiology*
  • Mycosis Fungoides / pathology*
  • Mycosis Fungoides / therapy
  • Neoplasm Staging
  • Prognosis
  • Registries
  • Retrospective Studies
  • Sex Distribution
  • Skin Neoplasms / epidemiology*
  • Skin Neoplasms / pathology*
  • Skin Neoplasms / therapy
  • Survival Rate